Notably, the considerable pro‐apoptotic effect of vFasL in comparison to sFasL could be observed also when targeting several different cell lines like K562 human leukemia cells and BJ human dermal fibroblasts (sees Figure S2, Supporting Information). The gene discussed is FASLG; the disease is leukemia.